J. Scott Garland - Net Worth and Insider Trading

Over the past 18 months, J. Scott Garland made no insider transaction in Calithera Biosciences Inc (CALA). Other recent insider transactions involving Calithera Biosciences Inc (CALA) include a net sale of 121,333 shares made by Deepika Pakianathan ,

In summary, during the past 3 months, insiders sold 0 shares of Calithera Biosciences Inc (CALA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 121,333 shares of Calithera Biosciences Inc (CALA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 121,333 shares.

Calithera Biosciences Inc (CALA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Portola Pharmaceuticals Inc (PTLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Portola Pharmaceuticals Inc (PTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Portola Pharmaceuticals Inc (PTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, J. Scott Garland made no insider transaction in Karyopharm Therapeutics Inc (KPTI). Other recent insider transactions involving Karyopharm Therapeutics Inc (KPTI) include a net sale of 199,037 shares made by Richard A. Paulson , a net sale of 66,291 shares made by Michael Mason , and a net sale of 47,442 shares made by Sohanya Roshan Cheng .

In summary, during the past 3 months, insiders sold 255,827 shares of Karyopharm Therapeutics Inc (KPTI) in total and bought 0 shares, with a net sale of 255,827 shares. During the past 18 months, 423,673 shares of Karyopharm Therapeutics Inc (KPTI) were sold and 41,140 shares were bought by its insiders, resulting in a net sale of 382,533 shares.

Karyopharm Therapeutics Inc (KPTI)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Relypsa Inc (RLYP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Relypsa Inc (RLYP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Relypsa Inc (RLYP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, J. Scott Garland made no insider transaction in Exelixis Inc (EXEL). Other recent insider transactions involving Exelixis Inc (EXEL) include a net sale of 247,500 shares made by Jeffrey Hessekiel , a net sale of 166,722 shares made by Patrick J. Haley , and a net purchase of 190,000 shares made by David Edward Johnson .

In summary, during the past 3 months, insiders sold 66,225 shares of Exelixis Inc (EXEL) in total and bought 190,000 shares, with a net purchase of 123,775 shares. During the past 18 months, 916,236 shares of Exelixis Inc (EXEL) were sold and 310,409 shares were bought by its insiders, resulting in a net sale of 605,827 shares.

Exelixis Inc (EXEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, J. Scott Garland made no insider transaction in Day One Biopharmaceuticals Inc (DAWN). Other recent insider transactions involving Day One Biopharmaceuticals Inc (DAWN) include a net sale of 126,607 shares made by Samuel C. Blackman , a net sale of 83,857 shares made by Jeremy Bender , and a net sale of 56,236 shares made by York Charles N Ii .

In summary, during the past 3 months, insiders sold 85,781 shares of Day One Biopharmaceuticals Inc (DAWN) in total and bought 0 shares, with a net sale of 85,781 shares. During the past 18 months, 374,613 shares of Day One Biopharmaceuticals Inc (DAWN) were sold and 2,244,684 shares were bought by its insiders, resulting in a net purchase of 1,870,071 shares.

Day One Biopharmaceuticals Inc (DAWN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, J. Scott Garland made no insider transaction in ALX Oncology Holdings Inc (ALXO). Other recent insider transactions involving ALX Oncology Holdings Inc (ALXO) include a net sale of 73,208 shares made by Jaume Pons , a net sale of 10,528 shares made by Shelly Pinto , and a net purchase of 4,400 shares made by Jason Lettmann .

In summary, during the past 3 months, insiders sold 70,000 shares of ALX Oncology Holdings Inc (ALXO) in total and bought 4,400 shares, with a net sale of 65,600 shares. During the past 18 months, 86,228 shares of ALX Oncology Holdings Inc (ALXO) were sold and 4,400 shares were bought by its insiders, resulting in a net sale of 81,828 shares.

ALX Oncology Holdings Inc (ALXO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, J. Scott Garland made no insider transaction in Olema Pharmaceuticals inc (OLMA). Other recent insider transactions involving Olema Pharmaceuticals inc (OLMA) include a net sale of 263,181 shares made by Cyrus Harmon , a net sale of 44,370 shares made by David C. Myles , and a net sale of 8,742 shares made by Kovacs Shane William Charles .

In summary, during the past 3 months, insiders sold 75,000 shares of Olema Pharmaceuticals inc (OLMA) in total and bought 0 shares, with a net sale of 75,000 shares. During the past 18 months, 398,074 shares of Olema Pharmaceuticals inc (OLMA) were sold and 2,255,932 shares were bought by its insiders, resulting in a net purchase of 1,857,858 shares.

Olema Pharmaceuticals inc (OLMA)'s detailed insider trading history can be found in Insider Trading Tracker table.